Clinical trial
Fluconazole Versus Micafungin for Candida Bloodstream Infection in…
NCT00304772 · Kyoto University, Other · Withdrawn
Key facts
| NCT number | NCT00304772 |
|---|---|
| Title | Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients |
| Official title | A Randomized Comparative Study of Fluconazole Versus Micafungin for the Treatment of Candida Bloodstream Infection in Non-Neutropenic Patients |
| Lead sponsor | Kyoto University, Other |
| Collaborators | Pfizer Industry Astellas Pharma Inc |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Candidiasis, Sepsis |
| Intervention type | Drug |
| Interventions | Fluconazole, Micafungin |
| Enrollment | 0 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Mar 20, 2006 |
| Last update posted | Jun 14, 2024 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: